Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 7 UNKNOWN 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Colorectal Neoplasms 1 Colorectal Cancer Metastatic 1

Interventions

Fluorouracil 21 Oxaliplatin 17 Leucovorin 17 Bevacizumab 17 Irinotecan 13 Panitumumab 12 Cetuximab 12 IFL protocol 9 Capecitabine 9 pembrolizumab 7 Radiotherapy 7 Pemetrexed 5 Gemcitabine 5 labetuzumab 3 conatumumab 3 Cisplatin 3 Carboplatin 3 Albumin-Bound Paclitaxel 3 5,11-methenyltetrahydrohomofolate 3 130-nm albumin-bound paclitaxel 3 vatalanib 2 trametinib 2 spartalizumab 2 pegfilgrastim 2 ganitumab 2 encorafenib 2 dostarlimab 2 Ramucirumab 2 Paclitaxel 2 Melphalan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Rectal Neoplasms × raltitrexed × Clear all

NCT00590278 2008-01-25

TOMUDEX

AstraZeneca

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡